Successful Pregnancy and Persistent Polyclonal B Cell Lymphocytosis (PPBL): A Case Study of a Rare Co-Existence.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
22 Dec 2021
22 Dec 2021
Historique:
entrez:
22
12
2021
pubmed:
23
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
BACKGROUND Persistent polyclonal B cell lymphocytosis (PPBL) is a benign clinical condition, which is characterized by persistent absolute polyclonal B lymphocytosis (>4.0 K/μL), with the presence of circulating binucleated lymphocytes on the peripheral blood smear and an extra 3 chromosome long arm i(3q) in most cases. Immunophenotype reveals the polyclonal population of B cell lymphocytes with expression of CD19, CD20, and CD22 antigens, and kappa and lambda immunoglobulin light chains. Patients are mostly asymptomatic. Although PPBL has a benign clinical course and does not affect the survival expectancy of most patients, pregnancy seems to be extremely rare in these patients, as only 1 case reported so far. Although the real role of immunologic disorders, possibly PPBL, in recurrent pregnancy losses remains unclear, the rarity of successful pregnancy in PPBL patients could be attributed to the possible association of PPBL with infertility or recurrent miscarriages. CASE REPORT In the present study we present the second published case of a woman with a typical PPBL and recurrent pregnancy loss with a successful pregnancy outcome. Close clinical and laboratory monitoring in combination with the administration of thromboprophylaxis and the induction of mild immunosuppression with low-dose prednisolone may have contributed to the successful outcome of the pregnancy. CONCLUSIONS In conclusion and taking all these findings into consideration, pregnancy in patients with PPBL seems to be extremely rare and the contribution of PPBL to the 2 previous miscarriages in our case could not be excluded.
Identifiants
pubmed: 34936642
pii: 933746
doi: 10.12659/AJCR.933746
pmc: PMC8713077
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e933746Références
Cancers (Basel). 2021 Jun 09;13(12):
pubmed: 34207634
Clin Exp Immunol. 1983 Aug;53(2):437-43
pubmed: 6603933
Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):430-438
pubmed: 29488292
N Engl J Med. 1982 Jul 22;307(4):232-6
pubmed: 6979709
Carcinogenesis. 2006 Feb;27(2):337-43
pubmed: 16123119
Best Pract Res Clin Obstet Gynaecol. 2012 Feb;26(1):91-102
pubmed: 22079389
J Clin Med. 2021 Feb 20;10(4):
pubmed: 33672505
Leukemia. 2009 Feb;23(2):419-22
pubmed: 18668130
Br J Haematol. 1999 Mar;104(3):486-93
pubmed: 10086784
Genes Chromosomes Cancer. 1997 Aug;19(4):233-40
pubmed: 9258658
Clin Exp Immunol. 2013 Feb;171(2):124-34
pubmed: 23286939
Blood. 2011 Jun 23;117(25):6948-51
pubmed: 21527518
Onco Targets Ther. 2008 Oct 01;1:59-66
pubmed: 21127753
Hum Reprod Update. 2008 Sep-Oct;14(5):497-517
pubmed: 18552168
Practitioner. 2014 May;258(1771):25-8, 3
pubmed: 25055407
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):169-78
pubmed: 24047642
J Clin Exp Hematop. 2015;55(2):77-82
pubmed: 26490519
BMC Res Notes. 2016 Mar 02;9:138
pubmed: 26935937
Br J Haematol. 1994 Oct;88(2):275-80
pubmed: 7803270
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):479-84
pubmed: 8552665
Genes Chromosomes Cancer. 1999 Nov;26(3):221-8
pubmed: 10502320
Leuk Lymphoma. 2004 Jul;45(7):1401-6
pubmed: 15359640
Leuk Lymphoma. 1996 Jan;20(3-4):275-9
pubmed: 8624467
Thromb Haemost. 2011 Feb;105(2):295-301
pubmed: 21103659
Trials. 2009 Nov 10;10:102
pubmed: 19903335